BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:17 PM
 | 
Jul 28, 2008
 |  BC Extra  |  Clinical News

Titan's Probuphine meets endpoint

Titan (AMEX:TTP) said Probuphine met the primary endpoint in a Phase III trial to treat opiate...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >